GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » China Dasheng Biotechnology Co (OTCPK:CDBT) » Definitions » Net Income From Continuing Operations

CDBT (China Dasheng Biotechnology Co) Net Income From Continuing Operations : $-0.97 Mil (TTM As of Jun. 2023)


View and export this data going back to 2007. Start your Free Trial

What is China Dasheng Biotechnology Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. China Dasheng Biotechnology Co's net income from continuing operations for the six months ended in Jun. 2023 was $-0.97 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.97 Mil.


China Dasheng Biotechnology Co Net Income From Continuing Operations Historical Data

The historical data trend for China Dasheng Biotechnology Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Dasheng Biotechnology Co Net Income From Continuing Operations Chart

China Dasheng Biotechnology Co Annual Data
Trend Oct06 Oct07 Jun08 Jun22 Jun23
Net Income From Continuing Operations
-0.02 -0.07 4.64 - -0.97

China Dasheng Biotechnology Co Semi-Annual Data
Oct06 Oct07 Jun22 Jun23
Net Income From Continuing Operations -0.02 -0.07 - -0.97

China Dasheng Biotechnology Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Dasheng Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
10/8 Inventory Court, Suite 200-A, Arundel, QLD, AUS, 4214
China Dasheng Biotechnology Co is a design and development company that focuses on permanent magnets as the driving force, rather than a motor.